Neuroprotective effects of the surfactant poloxamer 188 in excitotoxicity and underlying mechanisms

Chinese Pharmacological Bulletin

Volumn 26, Issue 11, 2010, Pages 1418-1424

  Li, Chun Hua ^a,b   Wang, Yan ^b   Qin, Zheng Hong ^b  

^a SOOCHOW UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

DRAM; Excitotoxicity; I B ; LAMP 2; Poloxamer 188; Quinolinic acid

Indexed keywords

I KAPPA B ALPHA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLOXAMER; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPHAGY; CELL COUNT; CELL LOSS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; DRUG MECHANISM; EXCITOTOXICITY; NERVE CELL LESION; NEUROPROTECTION; NISSL STAINING; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 79952344618     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gao X, Hu H. Quality control of the proteins associated with neurodegenerative diseases[J]. Acta Biochim Biophys Sin (Shanghai), 2008, 40(7):612-8. (Pubitemid 352009083)
2. Zhang Y Y, Shi L L, Hao D H, et al. The actions of Bcl-2 on anti-ischemic neuron injury and the effects of anti-ischemic drugs on Bcl-2[J]. Chin Pharmacol Bull, 2010, 26(1):21-4.
3. Liu C, Guo J. Relationship between exendin-4 and neurodegenerative[J]. Chin Pharmacol Bull, 2010, 26(5):566-9.
4. Sanberg P R, Calderon S F, Giordano M, et al. The quinolinic acid model of Huntington's disease: locomotor abnormalities[J]. Exp Neurol, 1989, 105(1):45-53. (Pubitemid 19198876)
5. Jewell R C, Khor S P, Kisor D F, et al. Pharmacokinetics of Rheo-thRx injection in healthy male volunteers[J]. J Pharm Sci, 1997, 86(7):808-12. (Pubitemid 27297492)
6. Lee R C, River L P, Pan F S, et al. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo[J]. Proc Natl Acad Sci USA, 1992, 89(10):4524-8.
7. Ng R, Metzger J M, Claflin D R, et al. Poloxamer 188 reduces the contraction-induced force decline in lumbrical muscles from mdx mice[J]. Am J Physiol Cell Physiol, 2008, 295(1):C146-50.
8. Sharma V, Stebe K, Murphy J C, et al. Poloxamer 188 decreases susceptibility of artificial lipid membranes to electroporation[J]. Biophys J, 1996, 71(6):3229-41. (Pubitemid 26422365)
9. Greenebaum B, Blossfield K, Hannig J, et al. Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation[J]. Burns, 2004, 30(6):539-47. (Pubitemid 39092346)
10. Serbest G, Horwitz J, Jost M, et al. Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma[J]. FASEB J, 2006, 20(2):308-10. (Pubitemid 46671153)
11. Marks J D, Pan C Y, Bushell T, et al. Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection[J]. FASEB J, 2001, 15(6):1107-9.
12. Cadichon S B, Le Hoang M, Wright D A, et al. Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats[J]. J Neurosurg, 2007, 106(1 Suppl):36-40.
13. Qin Z H, Chen R W, Wang Y, et al. Nuclear factor kappaB nuclear translocation upregulates c-Myc and p53 expression during NMDA receptor-mediated apoptosis in rat striatum[J]. J Neurosci, 1999, 19(10):4023-33. (Pubitemid 29222275)
14. Qin Z H, Wang Y, Chen R W, et al. Prostaglandin A(1) protects striatal neurons against excitotoxic injury in rat striatum[J]. J Pharmacol Exp Ther, 2001, 297(1):78-87.
15. Zhang X D, Wang Y, Wang Y, et al. p53 mediates mitochondria dysfunction-triggered autophagy activation and cell death in rat striatum[J]. Autophagy, 2009, 5(3):339-50.
16. Wang Y, Han R, Liang Z Q, et al. An autophagic mechanism is involved in apoptotic death of rat striatal neurons induced by the non-N-methyl-D-aspartate receptor agonist kainic acid[J]. Autophagy, 2008, 4(2):214-26. (Pubitemid 351231185)